Three Overlooked Stocks That Are Too Inexpensive to Dismiss
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 07 2026
0mins
Should l Buy MRK?
Source: Marketbeat
Market Outlook for 2026: Despite some companies trading at attractive valuations, 2026 may not be an ideal time for a value strategy due to various market pressures and the performance of promising firms.
Merck's Growth Potential: Merck is projected to see continued growth, driven by its cancer drug Keytruda, which is expected to generate significant sales and interest in ovarian cancer treatments, even as it prepares for patent expiration in 2028.
Campbell's Financial Challenges: Campbell's shares have declined significantly due to external pressures like tariffs and inflation, leading to modest declines in sales and earnings, although it maintains a strong dividend yield.
US Foods' Revenue Growth: US Foods is experiencing growth in profitability and revenue, supported by strong inventory management and a robust capital deployment strategy, positioning it well for future growth despite market challenges.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MRK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MRK
Wall Street analysts forecast MRK stock price to rise
16 Analyst Rating
11 Buy
5 Hold
0 Sell
Moderate Buy
Current: 110.230
Low
95.00
Averages
119.53
High
139.00
Current: 110.230
Low
95.00
Averages
119.53
High
139.00
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Global Bulk Filtration Market Expanding Rapidly
- Market Growth Drivers: The global bulk filtration market is significantly expanding due to industrialization and stringent environmental regulations, with projections indicating a market size reaching billions by 2031, compelling companies to invest in advanced filtration technologies to ensure compliance and enhance operational efficiency.
- Smart Filtration Technology Adoption: The integration of IoT and AI is making smart filtration systems a trend in the industry, enabling real-time monitoring of filtration efficiency and predictive maintenance, thereby reducing downtime and improving production efficiency.
- Self-Cleaning System Innovations: The development of self-cleaning filtration systems significantly reduces maintenance requirements and extends filter longevity, particularly valuable in water treatment and chemical processing industries, effectively lowering operational costs and enhancing production continuity.
- Rising Demand for Membrane Filtration: Membrane filtration technologies such as ultrafiltration and reverse osmosis are increasingly popular in water treatment and pharmaceuticals, with growing investments driven by the global demand for safe drinking water, further propelling market development.
See More
Merck KGaA Partners with Remepy to Develop Combination Drug-Digital Therapies
- Collaboration Agreement: Merck KGaA has signed a collaboration deal with Israeli-US startup Remepy to explore the therapeutic potential of combining drugs with app-based approaches, marking a significant entry for big pharma into the evolving digital therapy space, which is expected to enhance patient treatment outcomes.
- Multiple Program Development: The partnership will focus on several US-based programs to develop 'Hybrid Drugs' that integrate pharmaceuticals with personalized mobile app digital therapies, aiming to surpass the efficacy of standalone drugs and improve overall patient health outcomes.
- Regulatory Path Exploration: Developing a drug-digital therapy combination requires Phase I-III clinical trials for approval, and Merck and Remepy will leverage either the traditional combination product pathway or the Prescription Drug Use-Related Software (PDURS) framework to bring this innovative therapy to market in the US.
- Significant Market Potential: As the pharmaceutical industry seeks new ways to improve patient outcomes, Dr. Tsur of Remepy emphasizes that integrating drugs with digital technologies not only enhances treatment efficacy but also allows companies to differentiate themselves in a crowded market while avoiding reimbursement hurdles associated with standalone digital therapies.
See More
Memory Stocks Surge on AI Demand Outlook
- Memory Stocks Rise: Memory stocks like Sandisk and Micron surged as Melius Research highlighted sustained demand from the AI cycle, with Micron shares up 5% and Sandisk over 7%, indicating increased investor confidence and expected strong growth in the coming years.
- Strong Box Office Performance: Lionsgate Studios' film 'Michael' achieved $97 million in U.S. ticket sales and $217 million globally in its opening weekend, exceeding expectations by $30 million and becoming the highest-grossing biographical film, driving the stock up around 4% and reflecting strong market demand for quality content.
- Verizon's Earnings Beat: Verizon reported first-quarter adjusted earnings of $1.28 per share, surpassing the $1.20 expected by analysts, and raised its full-year guidance to $4.95-$4.99, leading to a 3% stock increase, showcasing the company's robust performance in a competitive telecom market.
- POET Technologies Plummets: POET Technologies' stock plummeted 48% after Celestial AI canceled all purchase orders and the company was accused of breaching confidentiality obligations, highlighting the critical importance of client relationships and contract compliance in the tech industry.
See More
Meta Signs Landmark Solar Power Deal with Overview Energy
- Solar Power Agreement: Meta has signed a deal with start-up Overview Energy to secure 1 gigawatt of solar capacity, with commercial delivery expected by 2030, aimed at powering its extensive AI infrastructure and enhancing its competitive edge in the AI sector.
- Funding Strategy: To finance the $50 billion Hyperion project, Meta has reportedly secured a $29 billion financing package from PIMCO and Blue Owl Capital, highlighting the immense capital required to sustain its position in the AI arms race.
- Challenges in China: Meta faces significant hurdles as China's National Development and Reform Commission mandates the unwinding of its $2 billion acquisition of Manus, reflecting regulatory pressures on foreign investments in the AI sector and potentially hindering Meta's autonomous AI ambitions.
- Market Outlook: Despite these challenges, Meta is actively expanding its AI technology, striving to maintain a leading position in the global AI market, particularly in competition with Microsoft and Alphabet, ensuring its technological innovations remain at the forefront.
See More
Market Dynamics and Corporate Acquisition Insights
- Market Stability: Despite rising oil prices due to stalled Iran peace talks, stock futures remain flat this morning, indicating a cautious investor sentiment following a historically volatile week.
- Legal Battle Intensifies: The trial between Elon Musk and Sam Altman begins today, with Musk suing Altman for $134 billion, alleging a breach of promise to keep ChatGPT a nonprofit, which could impact future IPO plans for both companies.
- Stock Price Surge: Qualcomm shares jumped 8% this morning on reports of a partnership with OpenAI to develop smartphone processing chips, highlighting OpenAI's intent to expand into hardware with its planned smartphone launch.
- Acquisition Proposal Surge: Sun Pharmaceutical's all-cash acquisition bid of $11.75 billion for Organon has led to a 17% increase in Organon's stock price this morning, reflecting strong market interest in the women's health sector.
See More
Chaos Erupts at White House Correspondents' Dinner Amid Security Incident
- White House Chaos: An armed man charged a security checkpoint during the White House Correspondents' Dinner, prompting evacuation of President Trump and officials, which has drawn widespread condemnation and highlights increasing political violence in the U.S.
- Investigation Closure: The Justice Department has ended its criminal investigation into Fed Chair Jerome Powell, clearing the way for Trump's nominee Kevin Warsh, which could significantly influence future monetary policy decisions.
- Iran Negotiation Halt: Trump canceled plans to send U.S. representatives to Pakistan for ceasefire talks, resulting in Brent crude prices surpassing $106 per barrel, exerting downward pressure on stock futures amid faltering peace talks.
- Tesla AI Testing: Tesla is beta testing xAI's Grok chatbot for in-vehicle voice commands, aiming to enhance driver experience, but safety experts warn that such features could distract drivers and compromise road safety.
See More
Global Bulk Filtration Market Expanding Rapidly
- Market Growth Drivers: The global bulk filtration market is significantly expanding due to industrialization and stringent environmental regulations, with projections indicating a market size reaching billions by 2031, compelling companies to invest in advanced filtration technologies to ensure compliance and enhance operational efficiency.
- Smart Filtration Technology Adoption: The integration of IoT and AI is making smart filtration systems a trend in the industry, enabling real-time monitoring of filtration efficiency and predictive maintenance, thereby reducing downtime and improving production efficiency.
- Self-Cleaning System Innovations: The development of self-cleaning filtration systems significantly reduces maintenance requirements and extends filter longevity, particularly valuable in water treatment and chemical processing industries, effectively lowering operational costs and enhancing production continuity.
- Rising Demand for Membrane Filtration: Membrane filtration technologies such as ultrafiltration and reverse osmosis are increasingly popular in water treatment and pharmaceuticals, with growing investments driven by the global demand for safe drinking water, further propelling market development.
See More
Merck KGaA Partners with Remepy to Develop Combination Drug-Digital Therapies
- Collaboration Agreement: Merck KGaA has signed a collaboration deal with Israeli-US startup Remepy to explore the therapeutic potential of combining drugs with app-based approaches, marking a significant entry for big pharma into the evolving digital therapy space, which is expected to enhance patient treatment outcomes.
- Multiple Program Development: The partnership will focus on several US-based programs to develop 'Hybrid Drugs' that integrate pharmaceuticals with personalized mobile app digital therapies, aiming to surpass the efficacy of standalone drugs and improve overall patient health outcomes.
- Regulatory Path Exploration: Developing a drug-digital therapy combination requires Phase I-III clinical trials for approval, and Merck and Remepy will leverage either the traditional combination product pathway or the Prescription Drug Use-Related Software (PDURS) framework to bring this innovative therapy to market in the US.
- Significant Market Potential: As the pharmaceutical industry seeks new ways to improve patient outcomes, Dr. Tsur of Remepy emphasizes that integrating drugs with digital technologies not only enhances treatment efficacy but also allows companies to differentiate themselves in a crowded market while avoiding reimbursement hurdles associated with standalone digital therapies.
See More
Memory Stocks Surge on AI Demand Outlook
- Memory Stocks Rise: Memory stocks like Sandisk and Micron surged as Melius Research highlighted sustained demand from the AI cycle, with Micron shares up 5% and Sandisk over 7%, indicating increased investor confidence and expected strong growth in the coming years.
- Strong Box Office Performance: Lionsgate Studios' film 'Michael' achieved $97 million in U.S. ticket sales and $217 million globally in its opening weekend, exceeding expectations by $30 million and becoming the highest-grossing biographical film, driving the stock up around 4% and reflecting strong market demand for quality content.
- Verizon's Earnings Beat: Verizon reported first-quarter adjusted earnings of $1.28 per share, surpassing the $1.20 expected by analysts, and raised its full-year guidance to $4.95-$4.99, leading to a 3% stock increase, showcasing the company's robust performance in a competitive telecom market.
- POET Technologies Plummets: POET Technologies' stock plummeted 48% after Celestial AI canceled all purchase orders and the company was accused of breaching confidentiality obligations, highlighting the critical importance of client relationships and contract compliance in the tech industry.
See More
Meta Signs Landmark Solar Power Deal with Overview Energy
- Solar Power Agreement: Meta has signed a deal with start-up Overview Energy to secure 1 gigawatt of solar capacity, with commercial delivery expected by 2030, aimed at powering its extensive AI infrastructure and enhancing its competitive edge in the AI sector.
- Funding Strategy: To finance the $50 billion Hyperion project, Meta has reportedly secured a $29 billion financing package from PIMCO and Blue Owl Capital, highlighting the immense capital required to sustain its position in the AI arms race.
- Challenges in China: Meta faces significant hurdles as China's National Development and Reform Commission mandates the unwinding of its $2 billion acquisition of Manus, reflecting regulatory pressures on foreign investments in the AI sector and potentially hindering Meta's autonomous AI ambitions.
- Market Outlook: Despite these challenges, Meta is actively expanding its AI technology, striving to maintain a leading position in the global AI market, particularly in competition with Microsoft and Alphabet, ensuring its technological innovations remain at the forefront.
See More
Market Dynamics and Corporate Acquisition Insights
- Market Stability: Despite rising oil prices due to stalled Iran peace talks, stock futures remain flat this morning, indicating a cautious investor sentiment following a historically volatile week.
- Legal Battle Intensifies: The trial between Elon Musk and Sam Altman begins today, with Musk suing Altman for $134 billion, alleging a breach of promise to keep ChatGPT a nonprofit, which could impact future IPO plans for both companies.
- Stock Price Surge: Qualcomm shares jumped 8% this morning on reports of a partnership with OpenAI to develop smartphone processing chips, highlighting OpenAI's intent to expand into hardware with its planned smartphone launch.
- Acquisition Proposal Surge: Sun Pharmaceutical's all-cash acquisition bid of $11.75 billion for Organon has led to a 17% increase in Organon's stock price this morning, reflecting strong market interest in the women's health sector.
See More
Chaos Erupts at White House Correspondents' Dinner Amid Security Incident
- White House Chaos: An armed man charged a security checkpoint during the White House Correspondents' Dinner, prompting evacuation of President Trump and officials, which has drawn widespread condemnation and highlights increasing political violence in the U.S.
- Investigation Closure: The Justice Department has ended its criminal investigation into Fed Chair Jerome Powell, clearing the way for Trump's nominee Kevin Warsh, which could significantly influence future monetary policy decisions.
- Iran Negotiation Halt: Trump canceled plans to send U.S. representatives to Pakistan for ceasefire talks, resulting in Brent crude prices surpassing $106 per barrel, exerting downward pressure on stock futures amid faltering peace talks.
- Tesla AI Testing: Tesla is beta testing xAI's Grok chatbot for in-vehicle voice commands, aiming to enhance driver experience, but safety experts warn that such features could distract drivers and compromise road safety.
See More
